HM
Therapeutic Areas
Cyclerion Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CYC-126 | Treatment-Resistant Depression (TRD) | Phase 1 |
Leadership Team at Cyclerion Therapeutics
RG
Regina Graul, PhD
President, Chief Executive Officer, Board Member
RC
Rhonda Chicko, CPA
Chief Financial Officer
ED
Errol De Souza, PhD
Chairman of the Board
PH
Peter Hecht, PhD
Board Member
MH
Michael Higgins
Board Member
SH
Steven Hyman, MD
Board Member
DK
Dina Katabi, PhD
Board Member